1. Home
  2. PBYI
  3. PBYI News

Latest Puma Biotechnology Inc (PBYI) News on February 22, 2025

Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results
PBYI

Business Wire

8 days ago

Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
PBYI

Business Wire

16 days ago

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

US Penny Stocks To Watch In January 2025
PBYI

Simply Wall St.

24 days ago

US Penny Stocks To Watch In January 2025

Is Now The Time To Put Puma Biotechnology (NASDAQ:PBYI) On Your Watchlist?
PBYI

Simply Wall St.

a month ago

Is Now The Time To Put Puma Biotechnology (NASDAQ:PBYI) On Your Watchlist?

Best Value Stocks to Buy for January 6th
PBYI

Zacks

2 months ago

Best Value Stocks to Buy for January 6th

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
PBYI

Business Wire

2 months ago

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Is Puma Biotechnology (PBYI) Stock Undervalued Right Now?
PBYI

Zacks

2 months ago

Is Puma Biotechnology (PBYI) Stock Undervalued Right Now?

US Penny Stocks With Promise: 3 Picks Under $200M Market Cap
PBYI

Simply Wall St.

2 months ago

US Penny Stocks With Promise: 3 Picks Under $200M Market Cap

Puma Biotechnology Stock Rises 24% in 3 Months: Here's Why
PBYI

Zacks

2 months ago

Puma Biotechnology Stock Rises 24% in 3 Months: Here's Why

Is Bristol Myers Squibb (BMY) Stock Undervalued Right Now?
PBYI

Zacks

2 months ago

Is Bristol Myers Squibb (BMY) Stock Undervalued Right Now?

Best Momentum Stocks to Buy for December 24th
PBYI

Zacks

2 months ago

Best Momentum Stocks to Buy for December 24th

Best Value Stocks to Buy for December 24th
PBYI

Zacks

2 months ago

Best Value Stocks to Buy for December 24th

With 49% stake, Puma Biotechnology, Inc. (NASDAQ:PBYI) seems to have captured institutional investors' interest
PBYI

Simply Wall St.

2 months ago

With 49% stake, Puma Biotechnology, Inc. (NASDAQ:PBYI) seems to have captured institutional investors' interest

Puma Biotechnology’s NERLYNX® Included in NCCN Clinical Practice Guidelines for the Treatment of Cervical Cancer with a HER2 Mutation
PBYI

Business Wire

2 months ago

Puma Biotechnology’s NERLYNX® Included in NCCN Clinical Practice Guidelines for the Treatment of Cervical Cancer with a HER2 Mutation

Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?
PBYI

Zacks

2 months ago

Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
PBYI

Business Wire

3 months ago

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Should Value Investors Buy Puma Biotechnology (PBYI) Stock?
PBYI

Zacks

3 months ago

Should Value Investors Buy Puma Biotechnology (PBYI) Stock?

Discovering Promising US Penny Stocks In November 2024
PBYI

Simply Wall St.

3 months ago

Discovering Promising US Penny Stocks In November 2024

PBYI Begins Phase II Study on Alisertib Combo in Breast Cancer
PBYI

Zacks

3 months ago

PBYI Begins Phase II Study on Alisertib Combo in Breast Cancer

Puma commences Phase II trial of alisertib for breast cancer treatment
PBYI

Clinical Trials Arena

3 months ago

Puma commences Phase II trial of alisertib for breast cancer treatment

PBYI

MT Newswires

3 months ago

Puma Biotechnology Launches Mid-Stage Trial of Alisertib to Treat Breast Cancer

Puma Biotechnology Announces Initiation of ALISCA™-Breast1 Phase II Trial of Alisertib in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
PBYI

Business Wire

3 months ago

Puma Biotechnology Announces Initiation of ALISCA™-Breast1 Phase II Trial of Alisertib in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer

We Think Puma Biotechnology's (NASDAQ:PBYI) Robust Earnings Are Conservative
PBYI

Simply Wall St.

3 months ago

We Think Puma Biotechnology's (NASDAQ:PBYI) Robust Earnings Are Conservative

Puma Biotechnology Third Quarter 2024 Earnings: Beats Expectations
PBYI

Simply Wall St.

3 months ago

Puma Biotechnology Third Quarter 2024 Earnings: Beats Expectations

PBYI Beats Q3 Earnings & Revenue Estimates, Revises '24 View, Stock Up
PBYI

Zacks

3 months ago

PBYI Beats Q3 Earnings & Revenue Estimates, Revises '24 View, Stock Up

PBYI

GuruFocus.com

3 months ago

Puma Biotechnology Inc (PBYI) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic ...

PBYI

Associated Press Finance

3 months ago

Puma Biotech: Q3 Earnings Snapshot

Puma Biotechnology Reports Third Quarter 2024 Financial Results
PBYI

Business Wire

3 months ago

Puma Biotechnology Reports Third Quarter 2024 Financial Results

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
PBYI

Business Wire

4 months ago

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

3 US Penny Stocks With Market Caps Under $700M
PBYI

Simply Wall St.

4 months ago

3 US Penny Stocks With Market Caps Under $700M

Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results
PBYI

Business Wire

4 months ago

Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results

With A Return On Equity Of 18%, Has Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Management Done Well?
PBYI

Simply Wall St.

4 months ago

With A Return On Equity Of 18%, Has Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Management Done Well?

Puma Biotechnology (NASDAQ:PBYI) investors are sitting on a loss of 79% if they invested five years ago
PBYI

Simply Wall St.

5 months ago

Puma Biotechnology (NASDAQ:PBYI) investors are sitting on a loss of 79% if they invested five years ago

Puma Biotechnology to Present at the H.C. Wainwright 26th Annual Global Investment Conference
PBYI

Business Wire

6 months ago

Puma Biotechnology to Present at the H.C. Wainwright 26th Annual Global Investment Conference

PBYI

MT Newswires

6 months ago

Federal Judge Rejects Patent Claims Supporting Puma Biotechnology's Breast Cancer Drug; Company Shares Down After Hours

Puma Biotechnology's (NASDAQ:PBYI) Earnings Offer More Than Meets The Eye
PBYI

Simply Wall St.

6 months ago

Puma Biotechnology's (NASDAQ:PBYI) Earnings Offer More Than Meets The Eye

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
PBYI

Business Wire

6 months ago

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Puma Biotechnology Second Quarter 2024 Earnings: Beats Expectations
PBYI

Simply Wall St.

7 months ago

Puma Biotechnology Second Quarter 2024 Earnings: Beats Expectations

Analysts Have Been Trimming Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target After Its Latest Report
PBYI

Simply Wall St.

7 months ago

Analysts Have Been Trimming Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target After Its Latest Report

Puma Biotechnology's (PBYI) Q2 Loss Narrower Than Expected
PBYI

Zacks

7 months ago

Puma Biotechnology's (PBYI) Q2 Loss Narrower Than Expected

Zacks.com featured highlights Abercrombie & Fitch, Puma Biotechnology, Spotify and Oddity
PBYI

Zacks

7 months ago

Zacks.com featured highlights Abercrombie & Fitch, Puma Biotechnology, Spotify and Oddity

PBYI

Associated Press Finance

7 months ago

Puma Biotech: Q2 Earnings Snapshot

Puma Biotechnology Reports Second Quarter Financial Results
PBYI

Business Wire

7 months ago

Puma Biotechnology Reports Second Quarter Financial Results

Should Value Investors Buy Puma Biotechnology (PBYI) Stock?
PBYI

Zacks

7 months ago

Should Value Investors Buy Puma Biotechnology (PBYI) Stock?

Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2024 Financial Results
PBYI

Business Wire

7 months ago

Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2024 Financial Results

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
PBYI

Business Wire

8 months ago

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers
PBYI

GOBankingRates

8 months ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

Bumrah delivers as India beat Pakistan in low-scoring thriller
PBYI

AFP

8 months ago

Bumrah delivers as India beat Pakistan in low-scoring thriller

Italy beat Bosnia in final Euros warm-up
PBYI

AFP

8 months ago

Italy beat Bosnia in final Euros warm-up

Macron Calls French Legislative Election After Far-Right Surge
PBYI

Bloomberg

8 months ago

Macron Calls French Legislative Election After Far-Right Surge

Trump loyalists proud to support 'felon' at Las Vegas rally
PBYI

AFP

8 months ago

Trump loyalists proud to support 'felon' at Las Vegas rally

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia
PBYI

Business Insider

8 months ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women
PBYI

Insider Monkey

8 months ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase
PBYI

Reuters

8 months ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
PBYI

Business Wire

8 months ago

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Puma Biotechnology Announces Presentation of Findings from a Phase I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung Cancer
PBYI

Business Wire

9 months ago

Puma Biotechnology Announces Presentation of Findings from a Phase I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung Cancer

Puma Biotechnology Announces Presentation of Findings from a Phase II Study of Alisertib in Endocrine-Resistant Metastatic Breast Cancer (TBCRC 041)
PBYI

Business Wire

9 months ago

Puma Biotechnology Announces Presentation of Findings from a Phase II Study of Alisertib in Endocrine-Resistant Metastatic Breast Cancer (TBCRC 041)

Puma Biotechnology to Join Russell 3000 Index
PBYI

Business Wire

9 months ago

Puma Biotechnology to Join Russell 3000 Index

With 49% ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) has piqued the interest of institutional investors
PBYI

Simply Wall St.

9 months ago

With 49% ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) has piqued the interest of institutional investors

Puma Biotechnology (PBYI) Falls 38% in 3 Months: Here's Why
PBYI

Zacks

9 months ago

Puma Biotechnology (PBYI) Falls 38% in 3 Months: Here's Why

Puma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual Meeting
PBYI

Business Wire

9 months ago

Puma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual Meeting

Implied Volatility Surging for Puma Biotechnology (PBYI) Stock Options
PBYI

Zacks

9 months ago

Implied Volatility Surging for Puma Biotechnology (PBYI) Stock Options

Analysts Have Lowered Expectations For Puma Biotechnology, Inc. (NASDAQ:PBYI) After Its Latest Results
PBYI

Simply Wall St.

10 months ago

Analysts Have Lowered Expectations For Puma Biotechnology, Inc. (NASDAQ:PBYI) After Its Latest Results

Puma Biotechnology First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
PBYI

Simply Wall St.

10 months ago

Puma Biotechnology First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Puma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2024 Earnings Call Transcript
PBYI

Insider Monkey

10 months ago

Puma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2024 Earnings Call Transcript

Puma Biotechnology's (PBYI) Q1 Earnings and Revenues Beat
PBYI

Zacks

10 months ago

Puma Biotechnology's (PBYI) Q1 Earnings and Revenues Beat

PBYI

GuruFocus.com

10 months ago

Puma Biotechnology Inc (PBYI) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review of ...

Puma Biotechnology Inc (PBYI) Reports Q1 Financial Results, Misses Analyst Revenue and EPS Forecasts
PBYI

GuruFocus.com

10 months ago

Puma Biotechnology Inc (PBYI) Reports Q1 Financial Results, Misses Analyst Revenue and EPS Forecasts

PBYI

Associated Press Finance

10 months ago

Puma Biotech: Q1 Earnings Snapshot

Puma Biotechnology Reports First Quarter Financial Results
PBYI

Business Wire

10 months ago

Puma Biotechnology Reports First Quarter Financial Results

Is Puma Biotechnology, Inc. (NASDAQ:PBYI) A High Quality Stock To Own?
PBYI

Simply Wall St.

10 months ago

Is Puma Biotechnology, Inc. (NASDAQ:PBYI) A High Quality Stock To Own?

What's in Store for Puma Biotechnology (PBYI) in Q1 Earnings?
PBYI

Zacks

10 months ago

What's in Store for Puma Biotechnology (PBYI) in Q1 Earnings?

Puma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial Results
PBYI

Business Wire

10 months ago

Puma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial Results

Puma Biotechnology (NASDAQ:PBYI) shareholders have earned a 93% return over the last year
PBYI

Simply Wall St.

10 months ago

Puma Biotechnology (NASDAQ:PBYI) shareholders have earned a 93% return over the last year

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
PBYI

Business Wire

a year ago

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Puma Biotechnology (PBYI) Soars 14.0%: Is Further Upside Left in the Stock?
PBYI

Zacks

a year ago

Puma Biotechnology (PBYI) Soars 14.0%: Is Further Upside Left in the Stock?

Do Puma Biotechnology's (NASDAQ:PBYI) Earnings Warrant Your Attention?
PBYI

Simply Wall St.

a year ago

Do Puma Biotechnology's (NASDAQ:PBYI) Earnings Warrant Your Attention?

Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer
PBYI

Business Wire

a year ago

Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer

FDA Lifts Clinical Hold on Iovance's (IOVA) Lung Cancer Study
PBYI

Zacks

a year ago

FDA Lifts Clinical Hold on Iovance's (IOVA) Lung Cancer Study

J&J (JNJ) Secures Full FDA Nod for Rybrevant in Lung Cancer
PBYI

Zacks

a year ago

J&J (JNJ) Secures Full FDA Nod for Rybrevant in Lung Cancer

Puma Biotechnology, Inc. (NASDAQ:PBYI) Q4 2023 Earnings Call Transcript
PBYI

Insider Monkey

a year ago

Puma Biotechnology, Inc. (NASDAQ:PBYI) Q4 2023 Earnings Call Transcript

Puma Biotechnology, Inc. (NASDAQ:PBYI) Shares Could Be 47% Below Their Intrinsic Value Estimate
PBYI

Simply Wall St.

a year ago

Puma Biotechnology, Inc. (NASDAQ:PBYI) Shares Could Be 47% Below Their Intrinsic Value Estimate

PBYI

Thomson Reuters StreetEvents

a year ago

Q4 2023 Puma Biotechnology Inc Earnings Call

Why Puma Biotech (PBYI) is a Top Value Stock for the Long-Term
PBYI

Zacks

a year ago

Why Puma Biotech (PBYI) is a Top Value Stock for the Long-Term

Puma Biotechnology (PBYI) Q4 Earnings & Revenues Lag Estimates
PBYI

Zacks

a year ago

Puma Biotechnology (PBYI) Q4 Earnings & Revenues Lag Estimates

Amarin's (AMRN) Q4 Earnings and Revenues Surpass Estimates
PBYI

Zacks

a year ago

Amarin's (AMRN) Q4 Earnings and Revenues Surpass Estimates

Puma Biotechnology Inc (PBYI) Reports Positive Net Income for Q4 and Full Year 2023
PBYI

GuruFocus.com

a year ago

Puma Biotechnology Inc (PBYI) Reports Positive Net Income for Q4 and Full Year 2023

PBYI

Associated Press Finance

a year ago

Puma Biotech: Q4 Earnings Snapshot

Puma Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results
PBYI

Business Wire

a year ago

Puma Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results

Sarepta (SRPT) Q4 Earnings Beat Estimates, Revenues Up Y/Y
PBYI

Zacks

a year ago

Sarepta (SRPT) Q4 Earnings Beat Estimates, Revenues Up Y/Y

Mirum's (MIRM) Q4 Earnings Lag Estimates, Revenues Beat
PBYI

Zacks

a year ago

Mirum's (MIRM) Q4 Earnings Lag Estimates, Revenues Beat

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
PBYI

Business Wire

a year ago

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Rocket (RCKT) Registers Narrower-Than-Expected Loss in Q4
PBYI

Zacks

a year ago

Rocket (RCKT) Registers Narrower-Than-Expected Loss in Q4

Puma Biotechnology (PBYI) to Report Q4 Earnings: What's in Store?
PBYI

Zacks

a year ago

Puma Biotechnology (PBYI) to Report Q4 Earnings: What's in Store?

Puma Biotechnology to Participate in a Panel Discussion at TD Cowen’s 44th Annual Health Care Conference
PBYI

Business Wire

a year ago

Puma Biotechnology to Participate in a Panel Discussion at TD Cowen’s 44th Annual Health Care Conference

United Therapeutics (UTHR) Q4 Earnings & Sales Beat Estimates
PBYI

Zacks

a year ago

United Therapeutics (UTHR) Q4 Earnings & Sales Beat Estimates

AbbVie (ABBV) Announces Appointment of New CEO Robert Michael
PBYI

Zacks

a year ago

AbbVie (ABBV) Announces Appointment of New CEO Robert Michael

Pfizer's (PFE) Ulcerative Colitis Pill Velsipity Gets EU Nod
PBYI

Zacks

a year ago

Pfizer's (PFE) Ulcerative Colitis Pill Velsipity Gets EU Nod

Iovance (IOVA) Stock Rises on FDA Nod for Melanoma Drug Amtagvi
PBYI

Zacks

a year ago

Iovance (IOVA) Stock Rises on FDA Nod for Melanoma Drug Amtagvi

Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results
PBYI

Business Wire

a year ago

Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results

Share on Social Networks: